Tenascin C Promiscuously Binds Growth Factors via Its Fifth Fibronectin Type III-Like Domain
|
journal
|
April 2013 |
Induction of Aberrant Vascular Growth, But Not of Normal Angiogenesis, by Cell-Based Expression of Different Doses of Human and Mouse VEGF Is Species-Dependent
|
journal
|
February 2013 |
High-Throughput Flow Cytometry Purification of Transduced Progenitors Expressing Defined Levels of Vascular Endothelial Growth Factor Induces Controlled Angiogenesis In Vivo
|
journal
|
December 2009 |
Update on therapeutic vascularization strategies
|
journal
|
January 2009 |
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
|
journal
|
June 2003 |
Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ: Gene Therapy for Angiogenesis
|
journal
|
May 2002 |
Gene Therapy for Ischemic Cardiovascular Diseases: Some Lessons Learned from the First Clinical Trials
|
journal
|
November 2004 |
Polymers for pro- and anti-angiogenic therapy
|
journal
|
April 2007 |
Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis
|
journal
|
October 2002 |
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments
|
journal
|
June 2010 |
The shunt problem: control of functional shunting in normal and tumour vasculature
|
journal
|
July 2010 |
The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis
|
journal
|
April 2008 |
Therapeutic angiogenesis for critical limb ischaemia
|
journal
|
May 2013 |
Strategic Directions in Tissue Engineering
|
journal
|
December 2007 |
The well-tempered vessel
|
journal
|
May 2001 |
FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia
|
journal
|
December 2011 |
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
|
journal
|
October 2000 |
Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF
|
journal
|
February 2007 |
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
|
journal
|
December 1993 |
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction
|
journal
|
July 2007 |
Critical role of microenvironmental factors in angiogenesis
|
journal
|
May 2005 |
Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts
|
journal
|
July 2010 |
The Extracellular Matrix: Not Just Pretty Fibrils
|
journal
|
November 2009 |
Vascularization in Tissue Engineering
|
book
|
October 2020 |
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
|
journal
|
January 2007 |
Growth factor binding to the pericellular matrix and its importance in tissue engineering☆
|
journal
|
November 2007 |
The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain
|
journal
|
December 2010 |
Cell-Demanded Liberation of VEGF 121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth
|
journal
|
April 2004 |
The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor‐binding domain
|
journal
|
July 2010 |
New aspects in vascular gene therapy
|
journal
|
April 2010 |
Basic and Therapeutic Aspects of Angiogenesis
|
journal
|
September 2011 |
Vascularization in tissue engineering
|
journal
|
August 2008 |
Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering
|
text
|
January 2007 |
Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164
|
journal
|
April 2014 |
Integrin regulation of growth factor receptors
|
journal
|
April 2002 |
The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction
|
journal
|
January 2011 |
Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor
|
journal
|
February 2011 |
VEGF Gene Delivery to Muscle
|
journal
|
November 1998 |
Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164
|
text
|
January 2014 |
Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression
|
journal
|
May 2009 |
Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164
|
text
|
January 2014 |
Controlled Angiogenesis in the Heart by Cell-Based Expression of Specific Vascular Endothelial Growth Factor Levels
|
journal
|
October 2012 |
Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia
|
journal
|
December 2006 |
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF
|
journal
|
October 2006 |
Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors
|
journal
|
December 2013 |
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
|
journal
|
April 2002 |
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
|
journal
|
January 2013 |
Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix
|
journal
|
March 2013 |
Polymeric system for dual growth factor delivery
|
journal
|
November 2001 |
Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB
|
journal
|
June 2012 |
Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres
|
journal
|
April 2012 |
Extracellular Matrix and Cytokines: A Functional Unit
|
journal
|
January 2000 |
Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering
|
journal
|
September 2007 |
Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis
|
journal
|
February 2004 |
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors
|
journal
|
December 2009 |
Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing
|
journal
|
September 2011 |
Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation
|
journal
|
January 2008 |
Positional Control of Cell Fate Through Joint Integrin/Receptor Protein Kinase Signaling
|
journal
|
November 2003 |
Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes
|
journal
|
June 2013 |
Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor
|
journal
|
January 2000 |
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth
|
journal
|
December 2003 |
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
|
journal
|
August 2003 |
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.
|
text
|
January 2002 |
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
|
journal
|
March 2012 |
Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain.
|
journal
|
July 1991 |
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|
journal
|
April 1996 |
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
|
journal
|
January 2007 |
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
|
journal
|
April 1996 |
Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing
|
journal
|
February 2014 |
Therapeutic angiogenesis: controlled delivery of angiogenic factors
|
journal
|
June 2012 |
Vitronectin: Growth Factor Complexes Hold Potential as a Wound Therapy Approach
|
journal
|
June 2008 |
Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle
|
journal
|
May 2011 |
The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis
|
text
|
January 2008 |
The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165
|
journal
|
August 2013 |
Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression
|
journal
|
September 2000 |
Glomeruloid Microvascular Proliferation Follows Adenoviral Vascular Permeability Factor/Vascular Endothelial Growth Factor-164 Gene Delivery
|
journal
|
March 2001 |
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
|
journal
|
August 1996 |
Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation
|
journal
|
April 2000 |
Interactions between growth factor receptors and adhesion molecules: breaking the rules
|
journal
|
October 2003 |
Local Delivery of VEGF and SDF Enhances Endothelial Progenitor Cell Recruitment and Resultant Recovery from Ischemia
|
journal
|
April 2015 |
Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing
|
journal
|
March 2007 |
Interactions between extracellular matrix and growth factors in wound healing
|
journal
|
March 2009 |
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
|
journal
|
August 2000 |
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2
|
journal
|
May 2002 |
Heparin-II Domain of Fibronectin Is a Vascular Endothelial Growth Factor-Binding Domain: Enhancement of VEGF Biological Activity by a Singular Growth Factor/Matrix Protein Synergism
|
journal
|
October 2006 |
Human Studies of Angiogenic Gene Therapy
|
journal
|
October 2009 |
Blood Flow Remodels Growing Vasculature During Vascular Endothelial Growth Factor Gene Therapy and Determines Between Capillary Arterialization and Sprouting Angiogenesis
|
journal
|
December 2005 |
The “Heart Disease and Stroke Statistics—2013 Update” and the Need for a National Cardiovascular Surveillance System
|
journal
|
January 2013 |
Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis
|
journal
|
February 2004 |